Global Chest Drainage Catheters Market Size By Type (Regular Chest Drainage Catheters, Thoracentesis Catheters), By Application (Clinics, Hospitals), By Region, And Segment Forecasts, 2023 to 2032

The Global Chest Drainage Catheters Market was valued at USD 635 million in 2023 and is projected to surpass USD 1.01 billion by 2031, expanding at a CAGR of 6.1% during the forecast period from 2023 to 2031. Chest drainage catheters are vital medical devices used to remove air, blood, or other fluids from the pleural space, typically in patients with conditions such as pneumothorax, hemothorax, pleural effusions, or post-surgical complications. The rising prevalence of thoracic diseases, growing number of cardiothoracic surgeries, and increasing adoption of minimally invasive procedures are driving the market's growth.

Drivers

1. Rising Incidence of Cardiothoracic Diseases:

An increase in respiratory conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, and pneumonia globally has created a consistent demand for chest drainage catheters. Furthermore, thoracic trauma cases from road accidents and injuries continue to rise, supporting market growth.

2. Advancements in Catheter Technology:

Technological innovations have led to the development of more efficient, comfortable, and biocompatible catheters that reduce infection risk and patient discomfort. Features such as anti-kinking design, radiopaque strips, and improved drainage performance have enhanced clinical outcomes.

3. Growth in Surgical Interventions:

The global rise in surgical procedures, especially cardiac and thoracic surgeries, is significantly increasing the need for post-operative drainage management, further propelling market demand.

Restraints

1. Risk of Complications and Infections:

Improper catheter placement or prolonged use can lead to complications such as infections, tissue damage, and pneumothorax, posing a limitation to widespread usage.

2. Limited Awareness in Developing Regions:

Despite growing healthcare infrastructure, some developing regions still lack awareness about the availability and benefits of advanced chest drainage systems, hindering market penetration.

Opportunity

1. Emerging Markets and Increasing Healthcare Expenditure:

Countries in Asia-Pacific and Latin America are witnessing rising healthcare investments and infrastructure development. This offers lucrative growth opportunities for market players aiming to expand their presence in untapped markets.

2. Demand for Minimally Invasive Procedures:

The global shift toward minimally invasive surgeries due to benefits like quicker recovery, less pain, and reduced hospital stays is expected to fuel the adoption of compact, easy-to-insert chest drainage catheters.

Market by System Type Insights

The market is segmented into Thoracic Drainage Catheters, Multifunctional Catheters, and Needle-Based Catheters. In 2023, the Thoracic Drainage Catheters segment held the largest market share due to its wide usage in post-surgical drainage and treatment of pleural diseases. However, Multifunctional Catheters are expected to exhibit the fastest growth, driven by their enhanced usability, reduced need for multiple insertions, and increasing demand in trauma care and ICUs.

Market by End-use Insights

Based on end use, Hospitals dominated the market in 2023, accounting for more than 60% of global revenue. Hospitals are the primary centers for major thoracic surgeries and trauma treatment, necessitating the use of chest drainage systems. Ambulatory Surgical Centers (ASCs) are expected to grow at a notable rate during the forecast period, supported by the trend towards outpatient thoracic procedures.

Market by Regional Insights

North America led the global market in 2023, driven by advanced healthcare systems, high awareness, and the presence of major industry players. Asia-Pacific, however, is anticipated to witness the highest growth rate through 2031, owing to increasing healthcare expenditure, government initiatives to improve access to medical care, and a growing elderly population.

Competitive Scenario

Key players in the Global Chest Drainage Catheters Market include Teleflex Incorporated, Smiths Medical, Cook Medical, Medtronic, Medela AG, Atrium Medical Corporation (Getinge Group), Cardinal Health, and Redax S.p.A.. Companies are actively focusing on product innovation, geographic expansion, and strategic collaborations to maintain competitive advantage.

Key Developments:

In 2023, Teleflex Incorporated launched a new sterile, ready-to-use thoracic catheter set with enhanced kink resistance and drainage efficiency.

Smiths Medical in 2024 introduced a silicone-based multifunctional catheter for intensive care and surgical use.

Getinge Group expanded its catheter production facilities in 2025 to meet growing global demand, particularly in Asia.

Scope of Work – Global Chest Drainage Catheters Market

Report Metric Details

Market Size (2023) USD 635 million

Projected Market Size (2031) USD 1.01 billion

CAGR (2023–2031) 6.1%

Market Segments System Type (Thoracic, Multifunctional, Needle-based); End-use; Region

Growth Drivers Rise in thoracic procedures; Technological advancements

Opportunities Emerging markets; demand for minimally invasive care

FAQs

1) What is the current market size of the Global Chest Drainage Catheters Market?

The market was valued at USD 635 million in 2023.

2) What is the major growth driver of the Global Chest Drainage Catheters Market?

The major growth driver is the increasing prevalence of thoracic diseases and rise in surgical interventions.

3) Which is the largest region during the forecast period in the Global Chest Drainage Catheters Market?

North America accounted for the largest market share in 2023, while Asia-Pacific is expected to grow fastest.

4) Which segment accounted for the largest market share in the Global Chest Drainage Catheters Market?

The Thoracic Drainage Catheters segment led the market in 2023 based on system type.

5) Who are the key market players in the Global Chest Drainage Catheters Market?

Key players include Teleflex Incorporated, Smiths Medical, Medtronic, Cook Medical, and Getinge Group.